Isoray cesium - 131 seeds

Ended Awarded Last action

Contract number
HT001422F0045
Awardee
Awarding agency
Obligated
$100,000

Award facts

Contract value 100% obligated
$100,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$50,000
Original award $150,000

About this award

Isoray Medical, Inc. was awarded a firm fixed price blanket purchase agreement (BPA) call contract valued at one hundred thousand dollars ($100,000) by the Defense Health Agency to deliver cesium-131 seeds for brachytherapy medical applications. The contract has no set-aside designation and requires completion by December 30, 2021. Performance will occur in Bethesda, Maryland at the agency's headquarters. As the sole awardee and prime contractor, Isoray Medical will provide the radioactive cesium-131 seeds needed to support the Defense Health Agency's medical isotopes program through the end of the calendar year.

Quick answers

Who was awarded contract HT001422F0045?

HT001422F0045 was awarded to Isoray Medical, Inc. by Defense Health Agency (Department of Defense) on December 28, 2021.

How much is contract HT001422F0045 worth?

The government has obligated $100,000 on HT001422F0045.

Is contract HT001422F0045 an order under another contract?

Yes. HT001422F0045 is a BPA call under HT001419A0025, a blanket purchase agreement.

Was contract HT001422F0045 competed?

The extent of competition for HT001422F0045 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award